Dr Rafael Grossmann Joins FundamentalVR Global Medical Panel: Thought Leader and Pioneering Healthcare and Education Futurist

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

November 11, 2020

Dr. Rafael Grossmann, healthcare futurist, has joined FundamentalVR Global Medical Panel.

Dr. Rafael Grossmann joins an esteemed panel of healthcare leaders and medical professionals to advise the company as it continues to assess the latest advances in immersive technologies and deploy cutting-edge simulations that power a new era of training for medical educators, device manufacturers, and life science companies.

A respected thought leader and pioneering healthcare and education futurist, Dr. Grossmann is dedicated to integrating technology into medical care and driving innovations to improve the overall healthcare system. He is a full-time practicing surgeon in Maine, specializing in general, trauma, advanced laparoscopic, single incision, and robotic-assisted surgeries. In 2013, he was the first doctor ever to use Google Glass during live surgery and is a passionate advocate of technology’s transformative potential to improve patient care. A global speaker at events including TEDx, Exponential Medicine, and MedicineX, Dr. Grossmann often lectures on innovations in healthcare and how the growth in mobile and wearable platforms will improve connectivity, communication, and data management to help make medicine more efficient, intuitive, and less expensive.

“The COVID-19 pandemic has brought challenges, but resulted in huge advancements in the use of immersive technologies. Now a proven solution, we are actively bringing new products to market using virtual reality for medical device and life science companies, providing a scalable sales training platform with objective measurement to enable better skills transfer, remotely, bridging the physical divide at scale,’’ said Richard Vincent, co-founder, and CEO of FundamentalVR. “As a working surgeon and leading advocate for the future of medical technology, we are delighted to welcome Dr. Grossmann to our Global Medical Panel. I’m excited to work with him to explore new ways of helping surgeons, hospitals, and the wider health industry improve patient outcomes.”

FundamentalVR solutions are powered by its patented HapticVRTM technology architecture that mimics the physical cues of surgical actions, medical tools, and tissue variations within immersive, data-driven medical educational simulations. Delivered through its Fundamental Surgery platform, it allows users to experience the same sights, sounds, and feelings they would in a real operating room. Every user interaction from the surgical gaze, respect for tissue, and movement efficiency is measured and recorded to provide a level of analysis not currently available to life science companies.  It can be seen in action here.

Already in use throughout the world, Fundamental Surgery is a low-cost software platform, which uses readily available off-the-shelf hardware. It offers various modalities that fit each stage of learning. Additionally, it is the first solution to bring educational simulations accredited by medical professional bodies to standalone VR headsets such as Oculus Quest and HTC Vive Focus Plus.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.